Financial Analysts Consensus 2023 - 2025 Galenica Group | 11.01.2024 | ||||||||
2022 A | Elimination | 2022 A | Number of | Consensus | Highest | Median | Lowest | ||
in million CHF | (as reported) | Mediservice | (continuing) | estimates | 2023 E | Change | 2023 E | 2023 E | 2023 E |
Net Sales | 4'014.3 | 425.8 | 3'588.5 | 7 | 3'759.4 | 4.8% | 3'771.8 | 3'767.1 | 3'713.2 |
Products & Care | 2'029.6 | 445.9 | 1'583.7 | 6 | 1'668.5 | 5.4% | 1'692.3 | 1'662.1 | 1'645.5 |
Logistics and IT | 2'933.3 | - | 2'933.3 | 6 | 3'075.9 | 4.9% | 3'094.1 | 3'076.0 | 3'051.8 |
Corporate & Elimination | -948.6 | -20.0 | -928.6 | 6 | -987.1 | 6.3% | -947.4 | -982.3 | -1'038.0 |
EBIT adjusted 1) | 200.8 | 10.2 | 190.6 | 7 | 195.7 | 2.7% | 202.3 | 194.8 | 190.9 |
ROS | 5.0% | 5.3% | 5.2% | 5.4% | 5.2% | 5.1% | |||
Products & Care | 153.5 | 10.2 | 143.3 | 6 | 152.0 | 6.0% | 156.0 | 151.5 | 149.7 |
ROS | 7.6% | 9.0% | 9.1% | 9.2% | 9.1% | 9.1% | |||
Logistics and IT | 49.2 | - | 49.2 | 6 | 44.7 | -9.2% | 46.9 | 44.9 | 41.4 |
ROS | 1.7% | 1.7% | 1.5% | 1.5% | 1.5% | 1.4% | |||
Corporate & Elimination | -1.9 | - | -1.9 | 6 | -1.8 | -7.8% | 0.1 | -2.1 | -3.1 |
Net profit adjusted 1) | 165.7 | 8.5 | 157.2 | 7 | 159.3 | 1.3% | 167.2 | 156.9 | 154.6 |
Investments in tangible and intangible assets | 70.7 | 0.5 | 70.2 | 6 | 67.8 | -3.3% | 70.0 | 70.0 | 60.3 |
in % of net sales | 1.8% | 2.0% | 1.8% | 1.9% | 1.9% | 1.6% | |||
Dividend per share (in CHF, paid in the following year) | 2.20 | 2.20 | 6 | 2.24 | 1.6% | 2.30 | 2.23 | 2.20 | |
1) Excluding the effects of IAS 19 and IFRS 16 |
Financial Analysts Consensus 2023 - 2025 Galenica Group | 11.01.2024 | ||||||
Consensus | Number of | Consensus | Highest | Median | Lowest | ||
in million CHF | 2023 E | estimates | 2024 E | Change | 2024 E | 2024 E | 2024 E |
Net Sales | 3'759.4 | 7 | 3'911.5 | 4.0% | 3'952.0 | 3'915.1 | 3'859.1 |
Products & Care | 1'668.5 | 6 | 1'746.4 | 4.7% | 1'796.0 | 1'731.7 | 1'723.1 |
Logistics and IT | 3'075.9 | 6 | 3'186.5 | 3.6% | 3'210.9 | 3'184.1 | 3'154.3 |
Corporate & Elimination | -987.1 | 6 | -1'016.8 | 3.0% | -966.3 | -1'013.6 | -1'078.0 |
EBIT adjusted 1) | 195.7 | 7 | 211.5 | 8.1% | 224.8 | 210.0 | 204.3 |
ROS | 5.2% | 5.4% | 5.7% | 5.4% | 5.3% | ||
Products & Care | 152.0 | 6 | 161.1 | 6.0% | 170.0 | 160.2 | 157.3 |
ROS | 9.1% | 9.2% | 9.5% | 9.3% | 9.1% | ||
Logistics and IT | 44.7 | 6 | 52.0 | 16.4% | 57.7 | 53.5 | 43.3 |
ROS | 1.5% | 1.6% | 1.8% | 1.7% | 1.4% | ||
Corporate & Elimination | -1.8 | 6 | -1.4 | -21.4% | - | -1.6 | -2.4 |
Net profit adjusted 1) | 159.3 | 7 | 171.6 | 7.7% | 181.0 | 170.9 | 163.6 |
Investments in tangible and intangible assets | 67.8 | 6 | 68.5 | 0.9% | 70.0 | 69.8 | 63.2 |
in % of net sales | 1.8% | 1.7% | 1.8% | 1.8% | 1.6% | ||
Dividend per share (in CHF, paid in the following year) | 2.24 | 6 | 2.32 | 3.9% | 2.45 | 2.30 | 2.20 |
1) Excluding the effects of IAS 19 and IFRS 16 |
Financial Analysts Consensus 2023 - 2025 Galenica Group | 11.01.2024 | ||||||
Consensus | Number of | Consensus | Highest | Median | Lowest | ||
in million CHF | 2024 E | estimates | 2025 E | Change | 2025 E | 2025 E | 2025 E |
Net Sales | 3'911.5 | 7 | 4'063.6 | 3.9% | 4'133.0 | 4'071.4 | 3'999.9 |
Products & Care | 1'746.4 | 6 | 1'826.1 | 4.6% | 1'894.0 | 1'813.4 | 1'784.8 |
Logistics and IT | 3'186.5 | 6 | 3'299.9 | 3.6% | 3'339.3 | 3'299.0 | 3'250.7 |
Corporate & Elimination | -1'016.8 | 6 | -1'051.7 | 3.4% | -985.6 | -1'051.3 | -1'119.6 |
EBIT adjusted 1) | 211.5 | 7 | 223.3 | 5.6% | 243.1 | 221.2 | 214.7 |
ROS | 5.4% | 5.5% | 5.9% | 5.4% | 5.4% | ||
Products & Care | 161.1 | 6 | 170.2 | 5.6% | 182.0 | 168.2 | 165.3 |
ROS | 9.2% | 9.3% | 9.6% | 9.3% | 9.3% | ||
Logistics and IT | 52.0 | 6 | 55.4 | 6.5% | 61.0 | 56.2 | 46.6 |
ROS | 1.6% | 1.7% | 1.8% | 1.7% | 1.4% | ||
Corporate & Elimination | -1.4 | 6 | -1.9 | 39.8% | 0.1 | -1.8 | -5.5 |
Net profit adjusted 1) | 171.6 | 7 | 182.0 | 6.1% | 198.0 | 182.0 | 172.4 |
Investments in tangible and intangible assets | 68.5 | 6 | 69.3 | 1.2% | 72.2 | 70.0 | 66.0 |
in % of net sales | 1.7% | 1.7% | 1.7% | 1.7% | 1.6% | ||
Dividend per share (in CHF, paid in the following year) | 2.32 | 6 | 2.43 | 4.4% | 2.61 | 2.40 | 2.20 |
1) Excluding the effects of IAS 19 and IFRS 16 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Galenica AG published this content on 11 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 March 2024 11:23:23 UTC.